Top Story

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014

A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

“Our study indicates a strong association between low testosterone concentration and the severity of atherosclerotic plaques as well as other key atherosclerotic markers in middle-aged men with type 2 diabetes,” Javier Mauricio Farias, MD, of the Hospital Universitario Sanatorio Guemes in Buenos Aires, said in a press release. “The results of our study advance our understanding of the interplay between low testosterone and cardiovascular disease in patients with diabetes.”

Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke, according to research…
figure Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European Association for the…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to research published in…
CME
figure

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »
CME
figure

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »

Filter By:

In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke…
figure Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to…
figure In the Journals

Clopidogrel response impaired among patients with diabetes, CAD

September 4, 2014
Patients with diabetes and CAD experienced an impaired response to platelet P2Y12 receptor antagonist clopidogrel compared with those without…
In the Journals

Insulin use, dialysis predicted poor wound healing after endovascular therapy

August 28, 2014
Patients undergoing endovascular therapy for critical limb ischemia were significantly more likely to have non-healing wounds if they used insulin…
figure In the Journals Perspective

DEFINITIVE LE published: Directional atherectomy effective regardless of diabetes status

August 27, 2014
Patients with or without diabetes who underwent directional atherectomy for peripheral artery disease experienced similar rates of primary patency at…

Nutrition education lacking in medical training

August 26, 2014
A group of physicians are questioning how well doctors can provide nutrition information and counseling to patients, particularly those with CVD…

AHA and ADA: CV risk assessment, monitoring essential for patients with type 1 diabetes

August 21, 2014
A greater understanding of the pathophysiology, risk prediction and treatment of CVD in patients with type 1 diabetes is essential to minimize the…
figure FDA News

FDA opens dialogue on interim results of CV safety in diabetes drug trials

August 12, 2014
The FDA has launched a dialogue on how to handle confidentiality of the interim results for cardiovascular outcomes in diabetes treatment trials…
More Headlines »